is the current chair of the radiation oncology department of the Ghent University Hospital in Ghent, Belgium, and associate professor at the Ghent University. She graduated from the Catholic University in Leuven, where she acquired her degrees in Medicine, Radiation Oncology and Hospital and Health Care Management, and completed her PhD in cost accounting and economic evaluation of radiotherapy. Her clinical focus lies on radiation therapy for thoracic malignancies, with an additional interest for the role of radiotherapy in hematology and breast cancer. She is closely involved in the organizational aspects of radiotherapy, the position of radiotherapy in multidisciplinary oncology and the financial and health economic aspects of cancer care, in Europe and worldwide. She is interested in quality issues related to radiation oncology, in terms of quality assurance as well as the impact of radiation treatments on quality-of-life. She is former president of ESTRO and of the Belgian College for Physicians in Radiation Oncology. She is, a.o., (co-)steering the Health Economics in Radiation Oncology (ESTRO-HERO), Global Impact of Radiotherapy in Oncology (ESTRO-GIRO) and E2-RADIATE (EORTC-ESTRO Infrastructure for Radiotherapy in Europe) projects, as well as the Treatment Optimization and Health Systems Network of the European Cancer Organization. She is convinced that an optimal combination of clinical, translational and health services research is key to the future of radiation oncology and to advance the outcome of cancer patients, by sustaining innovation in and access to radiotherapy in a multidisciplinary oncology environment.